Oncopeptides - Articles and news items

Oncopeptides presents clinical results from Phase I/II study of melflufen and dexamethasone in patients with relapsed and relapsed refractory multiple myeloma

Industry news / 17 June 2015 / Victoria White

Oncopeptides has presented results from an ongoing study of melflufen with dexamethasone in patients with relapsed and relapsed refractory multiple myeloma…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+